Literature DB >> 16019724

Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.

Livio Pagano1, Morena Caira, Luana Fianchi.   

Abstract

Invasive fungal infections are an important cause of morbidity and mortality in patients with hematological malignancies, and in particular fungal pneumonia is the main clinical manifestation in this category of patients. The fungal agents responsible for this complication are various, but Aspergillus spp. and other molds such as Zygomycetes or Fusarium spp. represent the most frequently isolated micro-organisms. Less commonly, pneumonia could be due to other 'no-molds' fungal agents such as Candida spp, Cryptococcus spp, or Pneumocystis jirovecii . This review mainly focuses on practical aspects relevant to epidemiology, diagnosis and therapeutic management of the rare cases of pneumonia due to no-molds agents in patients affected by hematological malignancies.

Entities:  

Mesh:

Year:  2005        PMID: 16019724     DOI: 10.1080/07853890510037374

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  6 in total

1.  Impact of zygomycosis on microbiology workload: a survey study in Spain.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Patricia Muñoz; Ignacio Gadea; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

2.  Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans.

Authors:  Scott R Waterman; Moshe Hacham; Guowu Hu; Xudong Zhu; Yoon-Dong Park; Soowan Shin; John Panepinto; Tibor Valyi-Nagy; Craig Beam; Shahid Husain; Nina Singh; Peter R Williamson
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

3.  Fungal Isolates of the Respiratory Tract in Symptomatic Patients Hospitalized in Pulmonary Units: A Mycological and Molecular Epidemiologic Study.

Authors:  Zahra Rafat; Seyed Jamal Hashemi; Keyhan Ashrafi; Iraj Nikokar; Alireza Jafari; Abbas Rahimi Foroushani; Behrad Roohi; Zeinab Borjian Boroujeini; Niloofar Rashidi; Niki Najar-Shahri
Journal:  J Multidiscip Healthc       Date:  2020-07-22

4.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

5.  Increasing Pneumocystis pneumonia, England, UK, 2000-2010.

Authors:  Rishma Maini; Katherine L Henderson; Elizabeth A Sheridan; Theresa Lamagni; Gordon Nichols; Valerie Delpech; Nick Phin
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

6.  Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes.

Authors:  Yang Liu; Ke Zheng; Yecheng Liu; Huadong Zhu
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-02-20       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.